Oncolytics Biotech

ONCYNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$90.953 M

$0.71 -6.92%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$28.8M

Loss-making

Shares outstanding

127,510,505

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#312Anixa BiosciencesANIX$97.0M
#313Acrivon TherapeuticsACRV$92.1M
#314Oncolytics BiotechONCY$91.0M
#315RallybioRLYB$89.9M
#316Telomir PharmaceuticalsTELO$86.0M

What if Oncolytics Biotech were worth as much as…

Open the what-if tool →

Gold $30.2T

$237,109.64

Per share 332,412× higher

Bitcoin $1.74T

$13,658.91

Per share 19,149× higher

Nvidia $5.52T

$43,257.35

Per share 60,644× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Oncolytics Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.